Neogen reported $609.12M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agilent A:US $ 3632M 118M
Antares Pharma ATRS:US $ 127.96M 5.56M
Atrion ATRI:US 125.83M 5.87M
Avanos Medical Inc AVNS:US $ 443.5M 4.4M
Bio Rad Laboratories BIO:US $ 2289.09M 113.78M
Cerus CERS:US $ 185.59M 4.32M
Danaher DHR:US $ 15392M 1380M
Idexx Laboratories IDXX:US $ 1001.23M 96.57M
Illumina ILMN:US $ 5310M 332M
Meridian Bioscience VIVO:US $ 194.98M 6.68M
Nanostring Technologies NSTG:US $ 466.14M 8.31M
Neogen NEOG:US $ 609.12M 17.67M
Orasure Technologies OSUR:US $ 285.05M 7.36M
Pacific Biosciences Of California PACB:US $ 1188.84M 7.12M
Quidel QDEL:US $ 917.69M 365.03M
Rockwell Medical RMTI:US $ 52.4M 6.84M
Sientra SIEN:US 151.54M 7.63M
Staar Surgical STAA:US $ 248.12M 24.6M
Surmodics SRDX:US $ 94.11M 1.07M
Thermo Fisher Scientific TMO:US $ 19260M 1575M
Utah Medical Products UTMD:US $ 66.62M 9.36M
Zoetis ZTS:US $ 7048M 254M